APA (7th ed.) Citation

Huang, Y., Liao, W., Huang, J., Lin, Y., Yang, S., Huang, C., . . . Su, P. (2024). Long‐term safety and efficacy of glucagon‐like peptide‐1 receptor agonists in individuals with obesity and without type 2 diabetes: A global retrospective cohort study. Diabetes, obesity & metabolism, 26(11), 5222-5232. https://doi.org/10.1111/dom.15869

Chicago Style (17th ed.) Citation

Huang, Yu‐Nan, Wen‐Ling Liao, Jing‐Yang Huang, Yu‐Jung Lin, Shun‐Fa Yang, Chieh‐Chen Huang, Chung‐Hsing Wang, and Pen‐Hua Su. "Long‐term Safety and Efficacy of Glucagon‐like Peptide‐1 Receptor Agonists in Individuals with Obesity and Without Type 2 Diabetes: A Global Retrospective Cohort Study." Diabetes, Obesity & Metabolism 26, no. 11 (2024): 5222-5232. https://doi.org/10.1111/dom.15869.

MLA (9th ed.) Citation

Huang, Yu‐Nan, et al. "Long‐term Safety and Efficacy of Glucagon‐like Peptide‐1 Receptor Agonists in Individuals with Obesity and Without Type 2 Diabetes: A Global Retrospective Cohort Study." Diabetes, Obesity & Metabolism, vol. 26, no. 11, 2024, pp. 5222-5232, https://doi.org/10.1111/dom.15869.